Expect strong dealmaking and narrower valuations, says Erika López, corporate partner in Baker McKenzie’s Chicago office and a member of the Global Private Equity Practice.
Pharmacy spend is becoming a key value lever at US portfolio companies as PE firms up their focus on healthcare oversight, says RxBenefits’ Peter Lombardi.
In this fifth episode of the third season of the Disruption Matters podcast miniseries, we explore how technology can help at every stage of the talent management process.
In this fourth episode of the third season of the Disruption Matters podcast series, we explore how technology can help add speed and rigour to roll-up strategies.
In this third episode of the third season of the Disruption Matters podcast miniseries, we explore how technology can help portfolio companies during the middle period of the investment, when they may need to pivot to take advantage of new opportunities or address changing conditions.
In this second episode of the third season of the Disruption Matters podcast miniseries, we look at how technology is changing the nature of due diligence and improving investment decisions.
We kick off the third season of the Disruption Matters podcast miniseries with a look at the promise and peril for managers using artificial intelligence today.
The fifth and final episode of Disruption Matters season two delves into the ways PE firms can ensure they're creating value for all stakeholders.
Sherrese Clarke Soares of HarbourView Equity Partners, Lauren Dillard of Vista Equity Partners, Elizabeth Weymouth of Grafine Partners, and Amanda McKenna of Withum weigh in.
The fourth installment of Disruption Matters season two focuses on creating topline growth in a volatile era.